Latest Posts

The most recently published posts in all categories.

Multiple Pathways of Recovery 2019 Second Day Keynote


The beat of drums marked the start of Day 2 of the Multiple Pathways of Recovery Conference (MPRC). This morning’s keynote speaker was Don Coyhis of the Mohican Nation who began his presentation by introducing native American musicians whose traditional drumming and singing called attendees together. Coyhis is the President and Founder of White Bison, …Read more

Multiple Pathways of Recovery 2019 First Day

(11/13/2019) This year’s Multiple Pathways of Recovery conference (MPRC) began today. Bigger than last year’s — with nearly double the attendees — it comes at a time of greater urgency than ever for the recovery movement. And as Michael Askew, Director of Recovery Advocacy for the organizing force behind the conference, CCAR, pointed out, MPRC …Read more

Four Treatment Facilities Honored in Analysis of Post-Treatment Outcomes


This article concerns the first annual awards given to programs for post-care abstinence rates which ranged from 65%  for the Gold Winner to 42% for the Bronze winner.  The results were based on a study done on more than 3,000 patients nationwide and indicated a strong percentage of patients who were able to remain abstinent ...Read more

Brain Change in Addiction as Learning, Not Disease

An article by one of the leaders in addiction theory and practice, Marc Lewis, summarizing and comparing the learning model of addiction to the brain disease model of addiction. Lewis has been at the forefront of debate concerning addiction and presents compelling arguments for a broader understanding of addiction.   ...Read more

How America’s opioid epidemic could get even worse


This article is based on a large Rand Corporation report, The Future of Fentanyl and Other Synthetic Opioids, which concludes the following:  "... (1) fentanyl and other synthetic opioids are becoming dominant in some parts of the United States and Canada, but remain less common in other parts of these countries; (2) a confluence of ...Read more

New York attorney general exposes $1 billion in wire transfers by Sackler family


This article introduces an additional facet of the investigation into the Sackler family, its relationship to Purdue Pharma and the opioid crisis.  Although the Sackler family denies the allegations, the New York attorney general is claiming the family moved money in an attempt to protect it from investigators and/or litigation. This allegation comes on the ...Read more

Belief, Behavior, and Belonging: How Faith is Indispensable in Preventing and Recovering from Substance Abuse


This potentially game-changing study quantifies the economic value that faith-based programs bring to drug prevention and treatment. We plan to do a more complete analysis of the report's findings but wanted to make it available sooner rather than later as it was recently widely announced. Minimally, the report highlights the importance of supporting public policies ...Read more

Purdue Pharma offers $10-12 billion to settle opioid claims


According to this article and other news reports, the Sackler family is negotiating to settle the 2,000 suits that have been brought against Purdue Pharma for its role in causing the opioid crisis. The billion dollar settlement would involve payments from the Sackler family as well as revenue generated from Purdue's pharmaceuticals. According to the ...Read more

Johnson & Johnson Ordered To Pay Oklahoma $572 Million In Opioid Trial


This story summarizes the Oklahoma decision which calls for Johnson & Johnson to pay $572 million for its part in causing the opioid crisis in that state. This is the first ruling to hold pharmaceutical companies responsible for the opioid crisis.  The case relied on public nuisance law which requires those found guilty to pay ...Read more

It’s Positioned as the “Go-To Drug To Treat Opioid Addiction” But it has Downsides


This story highlights both arguments for and against the use of buprenorphine (Suboxone) to address the opioid crisis. The primary argument for is that it can save lives by helping patients to manage withdrawal symptoms.  The primary arguments against include: its widespread diversion to illegal use, the tendency for pharmacies where it is sold to ...Read more